2019
DOI: 10.1101/gr.239277.118
|View full text |Cite
|
Sign up to set email alerts
|

TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells

Abstract: The epigenetic regulator TET2 is frequently mutated in hematological diseases. Mutations have been shown to arise in hematopoietic stem cells early in disease development and lead to altered DNA methylation landscapes and an increased risk of hematopoietic malignancy. Here, we show by genome-wide mapping of TET2 binding sites in different cell types that TET2 localizes to regions of open chromatin and cell-type-specific enhancers. We find that deletion of Tet2 in native hematopoiesis as well as fully transform… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
92
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
2
2

Relationship

2
6

Authors

Journals

citations
Cited by 76 publications
(101 citation statements)
references
References 68 publications
8
92
0
1
Order By: Relevance
“…2c). Considering the connection between the two groups of DMRs and the chromatin states, we found that DMRs occurring in PMDs were mainly associated with heterochromatic regions, while non-PMD-DMRs were highly enriched at enhancers and active promoters, which were mainly associated with active demethylation [29][30][31][32][33][34][35][36] (Fig. 2d,e).…”
Section: A High Proportion Of Dna Demethylation Events Identified In mentioning
confidence: 94%
“…2c). Considering the connection between the two groups of DMRs and the chromatin states, we found that DMRs occurring in PMDs were mainly associated with heterochromatic regions, while non-PMD-DMRs were highly enriched at enhancers and active promoters, which were mainly associated with active demethylation [29][30][31][32][33][34][35][36] (Fig. 2d,e).…”
Section: A High Proportion Of Dna Demethylation Events Identified In mentioning
confidence: 94%
“…Loss of TET2 in preleukemic HSCs leads to DNA hypermethylation at up to one quarter of active enhancers, and rapid deregulation of corresponding genes, and similar patterns of enhancer methylation are found in TET2 mutant AMLs . ChIPseq studies in a myeloid cell model indicated that almost half of TET2 binding occurs at enhancers, and that TET2 plays a direct role in maintaining open chromatin and subsequent TF binding …”
Section: Global Alterations In Chromatin Organizationmentioning
confidence: 86%
“…235 ChIPseq studies in a myeloid cell model indicated that almost half of TET2 binding occurs at enhancers, and that TET2 plays a direct role in maintaining open chromatin and subsequent TF binding. 236 Several recent studies have used genome-wide techniques to survey the methylation landscape in AML compared to normal blood. In a mouse model, loss of TET2 can cooperate with Flt3-ITD mutations to remodel DNA methylation, including at the Gata2 locus with concomitant reduction in Gata2 mRNA expression, and increased methylation at the GATA2 locus is also observed in AML with mutated TET2 and FLT3-ITD.…”
Section: Dysregulation Mediated By Altered Cytosine Methylationmentioning
confidence: 99%
“…TET2 binds to enhancers and facilitates the recruitment of estrogen receptor‐α . The loss of TET2 in native hematopoiesis and transformed acute myeloid leukemia attenuates the binding of basic helix‐loop‐helix TFs on enhancers . Lineage‐specific TF PU.1 coimmunoprecipitates with TET2.…”
Section: Enrichment Of Oxidized Methylcytosine At Enhancersmentioning
confidence: 99%